Target intelligence / Profile preview

NFKB activating protein pseudogene 1 (NKAPP1)

Target: NKAPP1
Molecular classification: Other (Pseudogene)

Overview

NFKB activating protein pseudogene 1 (NKAPP1) is a human pseudogene (CXorf42) on chromosome X. It is not a protein-coding gene, lacks confirmed biological functions, and is not considered a therapeutic target, receptor, enzyme, or protein. There is no evidence of role in disease or drug interaction, and it should not be confused with the functional NKAP gene.

Other names: Putative uncharacterized protein CXorf42CXorf42FLJ36576NF-kappa-B-activating protein pseudogene 1

Beyond the preview

Go deeper on NFKB activating protein pseudogene 1 (NKAPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NFKB activating protein pseudogene 1 (NKAPP1).

Explore the full profile